I kinda like this deal. If Neuren went down the road of partnering with someone for 1 or 2 indications, I wouldn't be unsatisfied with a large upfront payment such as this. If there are up to 10 indications for 2591, partner for 1 or 2 of them and then develop the rest. Shareholders would get a healthy special dividend while they wait of the company to develop the other indications which should appease those wanting to see ROIs in the short term. I don't think it will ever happen though...
I kinda like this deal. If Neuren went down the road of...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$16.63 |
Change
-0.070(0.42%) |
Mkt cap ! $2.095B | |||
| Open | High | Low | Value | Volume |
| $16.68 | $16.86 | $16.51 | $4.012M | 240.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 982 | $16.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.66 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |